Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: How much progress has been made?

Journal of Clinical Oncology

Volumn 29, Issue 7, 2011, Pages 805-813

  Horan, John T ^a   Logan, Brent R ^a   Agovi Johnson, Manza A ^a   Lazarus, Hillard M ^a   Bacigalupo, Andrea A ^a   Ballen, Karen K ^a   Bredeson, Christopher N ^a   Carabasi, Matthew H ^a   Gupta, Vikas ^a   Hale, Gregory A ^a   Khoury, Hanna Jean ^a   Juckett, Mark B ^a   Litzow, Mark R ^a   Martino, Rodrigo ^a   McCarthy, Philip L ^a   Smith, Franklin O ^a   Rizzo, J Douglas ^a   Pasquini, Marcelo C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUOROURACIL; METHOTREXATE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; SIBLING; SURGICAL MORTALITY;

ADULT; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FORECASTING; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952356420     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.5001     Document Type: Article

References (35)

1. Boeckh M: The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 143:455-467, 2008
2. Engelhard D, Marks MI, Good RA: Infections in bone marrow transplant recipients. J Pediatr 108:335-346, 1986 (Pubitemid 16125949)
3. Upton A, Kirby KA, Carpenter P, et al: Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality. Clin Infect Dis 44:531-540, 2007 (Pubitemid 46233255)
4. Yanik GA, Ho VT, Levine JE, et al: The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood 112:3073-3081, 2008
5. Weiner RS, Bortin MM, Gale RP, et al: Interstitial pneumonitis after bone marrow transplantation: Assessment of risk factors. Ann Intern Med 104:168-175, 1986 (Pubitemid 16134699)
6. Bearman SI: The syndrome of hepatic venoocclusive disease after marrow transplantation. Blood 85:3005-3020, 1995
7. Glucksberg H, Storb R, Fefer A, et al: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295-304, 1974
8. Gale RP, Bortin MM, van Bekkum DW, et al: Risk factors for acute graft-versus-host disease. Br J Haematol 67:397-406, 1987 (Pubitemid 18032036)
9. Hahn T, McCarthy PL Jr, Zhang MJ, et al: Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol 26:5728-5734, 2008
10. Miano M, Labopin M, Hartmann O, et al: Haematopoietic stem cell transplantation trends in children over the last three decades: A survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39:89-99, 2007 (Pubitemid 46085227)
11. Chang C, Storer BE, Scott BL, et al: Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: Similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood 110:1379-1387, 2007 (Pubitemid 47281440)
12. Lee SJ, Klein J, Haagenson M, et al: High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 110:4576-4583, 2007 (Pubitemid 351377826)
13. Bunin NJ, Davies SM, Aplenc R, et al: Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. J Clin Oncol 26:4326-4332, 2008
14. Bunin N, Carston M, Wall D, et al: Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 99:3151-3157, 2002 (Pubitemid 34525292)
15. Ringdén O, Horowitz MM, Sondel P, et al: Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 81:1094-1101, 1993
16. Einsele H, Ehninger G, Hebart H, et al: Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815-2820, 1995
17. Slattery JT, Sanders JE, Buckner CD, et al: Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 16:31-42, 1995
18. Flomenberg N, Baxter-Lowe LA, Confer D, et al: Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104:1923-1930, 2004
19. Bowden RA, Slichter SJ, Sayers MH, et al: Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 78:246-250, 1991
20. Macias WL, Mueller BA, Scarim SK, et al: Continuous venovenous hemofiltration: An alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 18:451-458, 1991
21. Hilbert G, Gruson D, Vargas F, et al: Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487, 2001 (Pubitemid 32164899)
22. Pasquini M, Wang Z: CIBMTR Summary Slides, CIBMTR Newsletter, pp 6-11, 2009
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. Klein J, Moeschberger M: Survival Analysis: Techniques of Censored and Truncated Data (ed 2). New York, NY, Springer-Verlag, 2003
25. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-200, 1972
26. Weisdorf D, Spellman S, Haagenson M, et al: Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: Revised definitions to predict survival. Biol Blood Marrow Transplant 14:748-758, 2008 (Pubitemid 351773151)
27. Slovak ML, Kopecky KJ, Cassileth PA, et al: Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Group Study. Blood 96:4075-4083, 2000
28. Storb R, Deeg HJ, Whitehead J, et al: Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729-735, 1986 (Pubitemid 16124386)
29. Nash RA, Piñeiro LA, Storb R, et al: FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 88:3634-3641, 1996 (Pubitemid 26365603)
30. Slavin MA, Osborne B, Adams R, et al: Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: A prospective, randomized, double-blind study. J Infect Dis 171:1545-1552, 1995
31. Marr KA, Seidel K, Slavin MA, et al: Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial. Blood 96:2055-2061, 2000
32. Couban S, Simpson DR, Barnett MJ, et al: A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 100:1525-1531, 2002 (Pubitemid 34925122)
33. Bensinger WI, Martin PJ, Storer B, et al: Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175-181, 2001 (Pubitemid 32064138)
34. Pavlù J, Kew AK, Taylor-Roberts B, et al: Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase. Blood 115:4018-4020, 2010
35. Sorror ML, Maris MB, Storb R, et al: Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT. Blood 106:2912-2919, 2005 (Pubitemid 41510773)